A different TRAP220 expression in distinct histologic subtypes of lung adenocarcinoma and the prognostic significance

Lung Cancer

Volumn 71, Issue 3, 2011, Pages 312-318

  Yun, Jeanho ^a   Son, Choon Hee ^a   Um, Soo Jung ^a   Kwon, Hyuk Chan ^a   Lee, Kyung Eun ^a   Choi, Phil Jo ^a   Roh, Mee Sook ^a  

^a Dong A University College of Medicine   (South Korea)

Author keywords

Estrogen receptor ; Histologic subtypes of adenocarcinoma; Immunohistochemistry; Lung adenocarcinoma; Prognosis; TRAP220

Indexed keywords

ESTROGEN RECEPTOR BETA; HORMONE RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING PROTEIN; PROTEIN SUBUNIT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KAPLAN MEIER METHOD; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; TISSUE MICROARRAY; TUMOR GROWTH; TUMOR VOLUME; WESTERN BLOTTING;

ADENOCARCINOMA; ADULT; AGED; ESTROGEN RECEPTOR BETA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MEDIATOR COMPLEX SUBUNIT 1; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RECURRENCE; SURVIVAL ANALYSIS;

EID: 79851511466     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2010.06.012     Document Type: Article

References (26)

1. Wlabah M., Boroumand N., Castro C., El-Zeky F., Eltorky M. Changing trends in the distribution of the histologic types of lung cancer: a review of 4,439 cases. Ann Dagn Pathol 2007, 11:89-96.
2. Kerr K.M. Pulmonary adenocarcinomas: classificaiton and reporting. Histopthology 2009, 54:12-27.
3. Ali G., Donati V., Loggini B., Servadio A., Dell'Omodarme M., Prati M.C., et al. Different estrogen receptor β expression in distinct histologic subtypes of lung adenocarcinoma. Hum Pathol 2008, 39:1465-1473.
4. Kornberg R.D. Mediator and mechanism of transcriptional activation. Trends Biochem Sci 2005, 30:235-239.
5. Malik S., Roeder R.G. Dynamic regulation of pol II transcription by the mammalian Mediator complex. Trends Biochem Sci 2005, 30:256-263.
6. Taatjes D.J., Marr M.T., Tjian R. Regulatory diversity among metazoanco-activator complexes. Nat Rev Mol Cell Biol 2004, 5:403-410.
7. Malik S., Baek H., Wu W., Roeder R.G. Structural and functional characterization of PC2 and RNA polymerase II-associated subpopulations of metazoan mediator. Mol Cell Biol 2005, 25:2117-2129.
8. Yuan C.X., Ito M., Fondell J.D., Fu Z.Y., Roeder R.G. The TRAP220 component of a thyroid hormone receptor-associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion. Proc Natl Acad Sci USA 1998, 95:7939-7944.
9. Kang Y.K., Guermah M., Yuan C.X., Roeder R.G. The TRAP/Mediator coactivator complex interacts directly with estrogen receptors alpha and beta through the TRAP220 subunit and directly enhances estrogen receptor function in vitro. Proc Natl Acad Sci USA 2002, 99:2642-2647.
10. Warnmark A., Almlof T., Lerers J., Gustaffson J.A., Treuter E. Differential recruitment of the mammalian mediator subunit TRAP220 by estrogen receptor ERα and ERβ. J Biol Chem 2001, 276:23397-23404.
11. Zhu Y., Qi C., Jain S., Le Beau M.M., Espinosa R., Atkins G.B., et al. Amplification and overexpression of peroxisome proliferator-activated receptor binding protein (PBP/PPARBP) gene in breast cancer. Proc Natl Acad Sci USA 1999, 96:10848-10853.
12. Dougherty S.M., Mazhawidza W., Bohn A.R., Robinson K.A., Mattingly K.A., Blankenship K.A., et al. Gender difference in the activity but not expression of estrogen receptors α and β in human lung adenocarcinoma cells. Endocr Relat Cancer 2006, 13:113-134.
13. Detterbeck F.C., Boffa D.J., Tanoue L.T. The new lung cancer staging system. Chest 2009, 136:260-271.
14. Travis W.D., Brambilla E., Muller-Hermelink H.K., Harris C.C. Pathology and genetics of tumors of the lung, pleura, thymus and heart 2004, World Health Organization International Histological Classification of Tumours, IARC Press, Lyon.
15. Motoi N., Szoke J., Riely G.J., Seshan V.E., Kris M.G., Rusch V.W., et al. Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis. Am J Surg Pathol 2008, 32:810-827.
16. Hsu F.D., Nielsen T.O., Alkushi A., Dupuis B., Huntsman D., Liu C.L., et al. Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry. Mod Pathol 2002, 13:1374-1380.
17. Kreuzer M., Gerken M., Heinrich J., Kreienbrock L., Wichmann H.E. Hormonal factors and risk of lung cancer among women?. Int J Epidemiol 2003, 32:263-271.
18. Wu C.T., Chang Y.L., Shih J.Y., Lee Y.C. The significance of estrogen receptor beta in 301 surgically treated non-small cell lung cancers. J Thorac Cardiovasc Surg 2005, 130:979-986.
19. Patrone C., Cassel T.N., Pettersson K., Piao Y.S., Cheng G., Ciana P., et al. Regulation of postnatal lung development and homeostasis by estrogen receptor beta. Mol Cell Biol 2003, 23:8542-8552.
20. Burakov D., Wong C.W., Rachez C., Cheskis B.J., Freedman L.P. Functional interactions between the estrogen receptor and DRIP205, a subunit of the heteromeric DRIP coactivator complex. J Biol Chem 2000, 275:20928-20934.
21. Zhang X., Krutchinsky A., Fukuda A., Chen W., Yamamura S., Chait B.T., et al. MED/TRAP220 exists predominantly in a TRAP/Mediator subpopulation enriched in RNA polymerase II and is required for ER-mediated transcription. Mol Cell 2005, 19:89-100.
22. Ito M., Yuan C.X., Okano H.J., Darnell R.B., Roeder R.G. Involvement of the TRAP220 component of the TRAP/SMCC coactivator complex in embryonic development and thyroid hormone action. Mol Cell 2000, 5:683-693.
23. Frade R., Balbo M., Barel M. RB18A, whose gene is localized on chromosome 17q12-q21.1, regulates in vivo p53 transactivating activity. Cancer Res 2000, 60:6585-6589.
24. Vijavargia R., May M.S., Fondell J.D. A coregulatory role for the mediator complex in prostate cancer cell proliferation and gene expression. Cancer Res 2008, 67:4034-4041.
25. Ndong Jde L., Jean D., Rousselet N., Frade R. Down-regulation of the expression of RB18A/MED1, a cofactor of transcription, triggers strong tumorigenic phenotype of human melanoma cells. Int J Cancer 2009, 124:2597-2606.
26. Gade P., Singh A.K., Roy S.K., Reddy S.P., Kalvakolanu D.V. Down-regulation of the transcriptional mediator subunit Med1 contributes to the loss of expression of metastasis-associated dapk1 in human cancers and cancer cells. Int J Cancer 2009, 125:1566-1574.